James Reinstein is listed as a director on 7 SEC Form D filings by 1 issuer between Nov 2016 and Sep 2022: Monteris Medical US, Inc. (Minnetonka, MN — other health care — 2016–2022; $26.6M reported sold to 10 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside James Erickson (7 shared filings), Martin Emerson (7 shared filings), Matthew Strobeck (7 shared filings), Richard Emmitt (7 shared filings), Kirk Nielsen (5 shared filings) and 6 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around James. Each name links to their own page.
The issuer belongs to the sponsor group Monteris (14 issuers, $162.9M reported sold, 2014–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Monteris has 14 companies on file and $162.9M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 7 public filings for James Reinstein and found 7 differences, 1 worth asking the sponsor about: Amount sold went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.